Contineum Therapeutics, Inc. Class A Common Stock

CTNMNASDAQHealthcare● Active

$11.23

$-0.26(-2.26%)

Market Cap$419848980

P/E Ratio—

52W High$16.33

52W Low$3.57

Avg Volume273K

Open$11.66

Beta0.89

Employees Ownership Insider Trades

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CTNM · as of Mar 5, 2026

Latest filing snapshot

+10+24.39%vs prior year

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

+10

Growth % (1Y)

+24.39%

Revenue / Employee

—

Net Income / Employee

$-1.18M

Market Cap

$420M

CTNM Employee Count

2024 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)	SEC filing link
2026-03-05	2025-12-31	51	+10	+24.39%
2025-03-06	2024-12-31	41	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

AMRN

Amarin Corporation plc

275$293M #2

CAPR

Capricor Therapeutics, Inc.

Alto Neuroscience, Inc.

76$635M #5

CTNM

Contineum Therapeutics, Inc. Class A Common StockYOU

51$420M #6

CADL

Candel Therapeutics, Inc.

38$481M #7

ALDX

Aldeyra Therapeutics, Inc.

9$110M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CTNM peer comparison

About CTNM employees

CTNM Employees · Headcount

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) employee data is sourced from the annual SEC 10-K filing. As of 2025, Contineum Therapeutics, Inc. Class A Common Stock had 51 full-time employees globally. Full-time employees only. Global consolidated headcount.

Contineum Therapeutics, Inc. Class A Common Stock's workforce increased by 10 (24.39%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CTNM Employees · 5 questions

As of the latest SEC 10-K filing (2025), Contineum Therapeutics, Inc. Class A Common Stock had 51 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Contineum Therapeutics, Inc. Class A Common Stock employee counthow many employees does Contineum Therapeutics, Inc. Class A Common Stock haveCTNM total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-05